Aligned Genetics Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Yeon-Cheol Jung

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	20.5%
Management average tenure	no data
Board average tenure	no data

Recent management updates

Recent updates

If You Like EPS Growth Then Check Out Aligned Genetics (KOSDAQ:238120) Before It's Too Late

Apr 06

Update: Aligned Genetics (KOSDAQ:238120) Stock Gained 29% In The Last Three Years

Feb 11

CEO

Yeon-Cheol Jung (53 yo)

no data

Tenure

Mr. Yeon-Cheol Jung serves as the Chief Executive Officer at Aligned Genetics, Inc. (formerly known as Logos Biosystems, Inc.). Mr. Jung is an Insider at Aligned Genetics, Inc. (formerly known as Logos Bio...

Aligned Genetics Management

Management criteria checks 0/4

Key information

Recent management updates

No independent directors

No independent directors

Aligned Genetics, Inc., Annual General Meeting, Mar 29, 2021

Recent updates

Full year 2023 earnings released: EPS: ₩225 (vs ₩324 in FY 2022)

New minor risk - Share price stability

Investor sentiment improves as stock rises 20%

Full year 2022 earnings released: EPS: ₩324 (vs ₩771 in FY 2021)

No independent directors

Investor sentiment improved over the past week

No independent directors

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

If You Like EPS Growth Then Check Out Aligned Genetics (KOSDAQ:238120) Before It's Too Late

New 90-day low: ₩7,370

Update: Aligned Genetics (KOSDAQ:238120) Stock Gained 29% In The Last Three Years

New 90-day low: ₩8,440

Aligned Genetics, Inc., Annual General Meeting, Mar 29, 2021

New 90-day low: ₩8,980

New 90-day low: ₩9,360

New 90-day low: ₩9,940

New 90-day high - ₩10,900

New 90-day high - ₩10,500

CEO

Tenure